Business Description
Kodiak Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US50015M1099
Description
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.69 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.7 | |||||
| 3-Year EPS without NRI Growth Rate | -19.5 | |||||
| 3-Year FCF Growth Rate | -23.6 | |||||
| 3-Year Book Growth Rate | -33 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.35 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.89 | |||||
| 9-Day RSI | 64.37 | |||||
| 14-Day RSI | 67.77 | |||||
| 6-1 Month Momentum % | 122.67 | |||||
| 12-1 Month Momentum % | 97.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.42 | |||||
| Quick Ratio | 8.42 | |||||
| Cash Ratio | 8.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 1.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -79.23 | |||||
| ROA % | -42.85 | |||||
| ROIC % | -105.65 | |||||
| ROC (Joel Greenblatt) % | -113.76 | |||||
| ROCE % | -46.66 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.8 | |||||
| Price-to-Tangible-Book | 2.8 | |||||
| EV-to-EBIT | -1.89 | |||||
| EV-to-Forward-EBIT | -1.87 | |||||
| EV-to-EBITDA | -2.2 | |||||
| EV-to-Forward-EBITDA | -2.05 | |||||
| EV-to-FCF | -2.46 | |||||
| Price-to-Net-Current-Asset-Value | 34.65 | |||||
| Price-to-Net-Cash | 48.91 | |||||
| Earnings Yield (Greenblatt) % | -52.91 | |||||
| FCF Yield % | -28.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kodiak Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -3.346 | ||
| Beta | 1.04 | ||
| Volatility % | 118.46 | ||
| 14-Day RSI | 67.77 | ||
| 14-Day ATR (€) | 0.329451 | ||
| 20-Day SMA (€) | 7.36525 | ||
| 12-1 Month Momentum % | 97.57 | ||
| 52-Week Range (€) | 2.034 - 9.565 | ||
| Shares Outstanding (Mil) | 52.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kodiak Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kodiak Sciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kodiak Sciences Inc Frequently Asked Questions
What is Kodiak Sciences Inc(FRA:K27)'s stock price today?
The current price of FRA:K27 is €8.32. The 52 week high of FRA:K27 is €9.57 and 52 week low is €2.03.
When is next earnings date of Kodiak Sciences Inc(FRA:K27)?
The next earnings date of Kodiak Sciences Inc(FRA:K27) is 2025-03-28 Est..
Does Kodiak Sciences Inc(FRA:K27) pay dividends? If so, how much?
Kodiak Sciences Inc(FRA:K27) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers